Opendata, web and dolomites

H2020 projects about "inhibitors"

The page lists 238 projects related to the topic "inhibitors".

# achronym  title  year 
1 REGAIN REgeneration of inner ear hair cells with GAmma-secretase INhibitors to regain hearing in patients with sensorineural hearing loss 2015
2 QUANTPATTERN Quantitative analysis of Nodal/Lefty-mediated pattern formation 2015
3 DE-ORPHAN DEtermination of Orphan Receptor PHysiological Agonists and sigNals 2015
4 VEGFDANI Novel enhancers of functional recovery after stroke 2015
5 CannaPreg Development of pregnenolone derivatives as allosteric inhibitors of CB1 cannabinoid receptors for the treatment of schizophrenia and psychotic syndromes 2015
6 EPIMAC The next generation epigenetic medicine for inflammation 2015
7 HyMedPoly Drug-Free Antibacterial Hybrid Biopolymers for Medical Applications 2015
8 MULTISURF MULTI-functional metallic SURFaces via active Layered Double Hydroxide treatments 2015
9 SalHyd5 Characterization of Salmonella enterica hydrogenase-5 biosynthesis for developing novel anti-infective compounds 2015
10 Pharmcophore-DOS Pharmacophore guided diversity-oriented synthesis and its application in discovering inhibitors of protein-protein interactions between RAD51 and BRCA2 2015
11 EpiNKT Transcriptional and epigenetic control of innate-like T lymphocyte development 2015
12 BATTLE The molecular basis of NleB-mediated bacterial virulence 2016
13 TARGEPILIVER Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs. 2015
14 MBLIs New Approaches to Metallo-β-Lactamase Inhibitors 2015
15 PneumoCompetence Unravelling the mechanisms of competence induction by antibiotic stress in Streptococcus pneumoniae 2015
16 APCINTERACTIONS Molecular basis for securin and cyclin ubiquitylation by the anaphase-promoting complex (APC/C) 2016
17 2G BIOPIC Second Generation BIoethanol sustainable production based on Organosolv Process at atmospherIc Conditions 2015
18 jamclay Chemical Tools to Probe the Role of Bromodomains in the Parasite Trypanosoma cruzi 2016
19 MaSCheNav Mass Spectrometry-Based Chemoproteomic Profiling of Nav1.7, a Voltage-Gated Sodium Channel 2015
20 MELANOPARK Investigating the LRRK2-melanin connection through phosphoproteomics of isogenic melanoma cells 2015
21 AND Antibacterial (Nano)medicines Development 2015
22 CR-PHAGOCYTOSIS Complement-mediated phagocytosis in neutrophils 2015
23 EPIRIN EPIGENETIC REGULATION OF INFLAMMATION IN NAFLD 2015
24 IntestineUb The role of Ubiquitin System on the homeostatic control of stem cell maintenance and differentiation in crypt stem cells 2016
25 FLUOROKEF Incorporation of unnatural fluorinated amino acids to probe the function of the bacterial efflux system Kef in a cellular setting. 2015
26 ACM Cholesterol metabolism as a driver of prostate cancer aggressiveness 2015
27 TITLY Inhibition of the T-cell receptor signalling pathway for treatment of T-cell lymphoma 2015
28 PROVIST PROTEASES VISUALIZATION DURING TUMOR PROGRESSION 2016
29 STTDAA Synthesis of Truncated Tirandamycin A-D Derivatives as new Antihelminthic Agents 2015
30 CARDIOTOX Predicting Cardiotoxicity Induced by Kinase Inhibitors: From Systems Biology to Systems Pharmacology 2015
31 SENSITIVITYMARKERS Clinical validation of prognostic biomarkers of chemotherapy response in liquid biopsies 2015
32 SUMOblock Blocking SUMO conjugation as drug discovery strategy. 2015
33 MyNano Towards the design of Personalised Polymer-based Combination Nanomedicines for Advanced Stage Breast Cancer Patients 2015
34 REGiREG Regulating the immune regulators: targeting adaptive immune control 2015
35 ZF-MEL-CHEMBIO Chemical Biology in Zebrafish: Drug-Leads and New Targets in the Melanocyte Lineage and Melanoma 2015
36 RABIOPRED RABIOPRED - Clinical validation of BIOmarker assay to PREDict treatment response in Rheumatoid Arthritis (RA) patients 2015
37 US4GREENCHEM Combined Ultrasonic and Enzyme treatment of Lignocellulosic Feedstock as Substrate for Sugar Based Biotechnological Applications 2015
38 LEONID Lung cancEr fusiOn geNes: a new dIagnostic Device 2015
39 T6SS-PSEUDO-LIP Type VI-dependent Pseudomonas aeruginosa phospholipases and host manipulation 2016
40 TRIGGDRUG Reactions That Translate mRNA into Drug-like Molecules 2016
41 AUROMYC N-Myc and Aurora A: From Protein Stability to Chromosome TopologyN-Myc and Aurora A: From Protein Stability to Chromosome TopologyMyc and Aurora A: From Protein Stability to Chromosome Topology 2015
42 Phd Deciphering PI3K biology in health and disease 2015
43 HaemMetabolome Deciphering the Metabolism of Haematological Cancers 2015
44 p38Cure New breast cancer therapies based on available p38 MAPK inhibitors 2015
45 StemNicheOnWaveCrest New therapies for myeloproliferative diseases based on multi-stage and -system analyses of the haematopoietic stem-cell niche 2015
46 BIOVALID Clinical validation of the DiviTum assay in two high profile clinical studies in Europe 2015
47 Infarnosys Novel biomarker diagnostic system for the assessment of the prognosis of acute myocardial ischemia/reperfusion injury and infarction and the effectiveness of the treatment 2015
48 CODIC COmmercializing first-in-class dCTPase Inhibitors for treatment of hematological Cancers 2016
49 SWEETOOLS Smart Biologics: Developing New Tools in Glycobiology 2016
50 SAFEIMMUNOSUPPRESS Development of immunosuppressive treatments with better safety 2016
51 GvHDCure Understanding the dynamics of the immune system to cure graft-versus-host disease (GvHD). 2016
52 EVI1inCancer Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers 2016
53 PEP-PRO-RNA Peptide-derived bioavailable macrocycles as inhibitors of protein-RNA and protein-protein interactions 2016
54 PrecTherLSCC Precision Therapies in Lung Squamous Cell Carcinoma 2016
55 HeartAtaK Targeting the Anti-Target: From Structure to Drug in the heart Kv11.1 channel 2016
56 FCSSSLP First Chemoselective Synthesis and Structural Studies of Lasso Peptides 2016
57 MRCKa in cancer Targeting Cancer Cell Invasion and Metastasis by Inhibition of the Serine Kinase MRCKa 2016
58 BiCyHePepDi Bicyclic hetero peptidimer - a novel molecule format for therapeutic peptides 2016
59 NORVAS Therapeutic and Biomarker Potential of long non-coding RNAs in Vascular Disease 2016
60 ONCOINTRABODY Targeting common oncogenes with intracellular monobodies 2016
61 Wnt and CRC Therapeutic inhibition of the oncogenic Wnt/beta-catenin pathway in mismatch repair deficient hypermutant tumors 2017
62 2MoveMate4Melanoma A treatment for BRAF inhibitor resistant melanoma 2016
63 CHIKV-FBDD Structural investigation into functionality of Chikungunya virus nsP2 in replication complex and screening of small molecules for its inhibition 2016
64 MERC Molecular mechanisms regulating cardiovascular remodeling by Adamts1 2016
65 PeptiCrad Personalized oncolytic vaccines for cancer immunotherapy 2016
66 CHEMCHECK CHECKPOINTS IN CHECK: Novel Chemical Toolbox for Local Cancer Immunotherapy 2016
67 LeukaemiaTargeted Selecting genetic lesions with essential function for patients' leukaemia in vivo as targets for precision medicine 2016
68 BCM-UPS Dissecting the role of the ubiquitin proteasome system in the pathogenesis and therapy of B-cell malignancies 2016
69 PLEIO-RANK Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity 2016
70 CDK6-DrugOpp CDK6 in transcription - turning a foe in a friend 2016
71 ZMOD Blood Vessel Development and Homeostasis: Identification and Functional Analysis of Genetic Modifiers 2016
72 TNT-TUMORS Therapeutic approaches to enhance innate immunity against Tumors 2016
73 SIDSCA Defective DNA Damage Responses in Dominant Neurodegenerative Diseases 2016
74 TAROX Targeting oxidative repair proteins for treatment of cancer and inflammation 2016
75 MARS Mechanism of allosteric regulation of SHP2 phosphatase and its role in cancer and geneticdiseases: a multidisciplinary computational, structural and biological approach 2017
76 LSDiASD Leveraging Small Demethylase inhibitors for Autism Spectrum Disorder 2016
77 AD-VIP Alzheimer’s disease and AAV9: Use of a virus-based delivery system for vectored immunoprophylaxis in dementia. 2016
78 PDZnet Unraveling Principles of PDZ-mediated Cell Signaling 2016
79 Sphingolead Development of a potent dual GCS/GBA2 inhibitor as a best in class Gaucher therapeutic 2016
80 PolyP-FXII in cancer The polyphosphate/factor-XII pathway in cancer-driven thrombosis and tumor growth 2017
81 THERACAN Novel therapeutic strategies to treat pancreatic and lung cancer 2017
82 VGAP The Viral Genome Associated Proteome 2017
83 TKI resistance Resistance mechanisms to tyrosine kinase inhibitors in solid tumors 2016
84 NOTID Novel treatment of inflammatory diseases 2016
85 CHEMMINE Chemical proteome mining for functional annotation of disease relevant proteins 2017
86 TEDCIP Targeting epigenetic demethylases: development of covalent inhibitors and PROTACs (Proteolysis Targeting Chimeras). 2017
87 LIGER Identification of novel substrates for ubiquitin ligases involved in cell cycle and cell migration 2017
88 Targeting TopoII Mechanistic studies of metal-dependent DNA cleavage in Type II topoisomerase toward therational design of novel anticancer drugs 2017
89 GlycoModels 3D glyco-engineered models to address the role of glycosylation in gastric cancer clinical management 2017
90 RepliStressTiming Impact of replicative stress on DNA replication timing control 2017
91 BRAINHIB Integrated drug discovery approach to generate brain-penetrant inhibitors of glioblastoma cell proliferation 2018
92 CRISTONE Targeting CRISPR-based HDAC inhibitors to histones: a new tool for assessing mechanisms of class I HDAC inhibitors and developing chemical probes. 2017
93 RHOMBOSMALPS Enabling malaria rhomboid proteases as drug targets: usage of molecular cookie cutters to shape novel activity assays and inhibitors. 2017
94 DREMATURE DNA repair mechanisms and therapy resistance of BRCA2-deficient cancers 2018
95 DELLATECH New DELLA-based biotechnological tools for sustainable Agriculture 2017
96 TRIBBLES Characterizing the clinical relevance and the mechanism underlying TRIB2-mediated drug resistance to MEK inhibitiors in the context of melanoma 2018
97 ENDOCAM TARGETING ENDOTHELIAL CELL AND CANCER AMOEBOID MOVEMENT TO OVERCOME RESISTANCE TO ANTI-VEGF AND ANTI-PROTEASE THERAPIES 2017
98 SHAPPI Scaffold hybridization approach targeting PPIs 2017
99 DNAmethAML Investigation of aberrant DNA methylation in malignant haematopoiesis 2018
100 MSCFate Fate of mammary stem cells during tumorigenesis and clinical implications 2017
101 SIRFUNCT Chemical Tools for Unravelling Sirtuin Function 2017
102 PCAGED-KI Photocaged Kinase Inhibitors as Molecular Tools for Investigating Neurodegenerative Diseases 2017
103 IVORIaN RAS/C-RAF interaction: A new pharmacological target in Kras-driven lung cancer. 2017
104 LIsTEN β-Lactams as flaviviral NS3 protease inhibitors 2017
105 MUTAnTS A microfluidic high throughput approach to helicase biophysics 2018
106 MuSCel Genome Muscle Specific C. elegans Genome in health and disease: finding novel factors in 3D organization 2017
107 FimH-Mech The molecular mechanism of E. coli FimH pathogenicity 2017
108 SAMNets Investigation of adaptive design and rewiring of Survival-Apoptosis-Mitogenic (SAM) signalling transduction network 2017
109 INSPirAUTOR Understanding how Inositol Polyphosphates regulate autophagy and lipid body formation in photosynthetic organisms: crosstalk with TOR signaling. 2018
110 ONCOPHAGY Novel Atg4B-inhibitors and dual [Atg4B-carbonic anhydrase]inhibitors for interfering with cytoprotective mechanisms of cancercells in the acidic tumor micro-environment. 2017
111 DUALITY An Integrated Computational and Experimental Approach to Rapid Synthesis of Highly Selective Dual-Targeted HDAC/CK2, MMP2/CK2 Inhibitors 2018
112 PI3K-VAs Activation of PI3K signalling in the pathogenesis of Vascular Anomalies 2018
113 altEJrepair Characterisation of DNA Double-Strand Break Repair by Alternative End-Joining: Potential Targets for Cancer Therapy 2017
114 INTUMORX Elucidation of intratumoral heterogeneity in Kras-driven cancers 2017
115 PERCAL Chemical building blocks from versatile MSW biorefinery 2017
116 NO-ESKAPE Addressing Antibiotic Resistance: New Strategies for Overcoming the ESKAPE Pathogens 2017
117 ChAMPioN Game-changing Precision Medicine for Curing All Myeloproliferative Neoplasms 2018
118 Ub-BAC Dissecting and targeting ubiquitin networks in the course of bacterial infections 2017
119 NOVITREP Novel viral therapy through targeting DNA repair 2017
120 Tumor-Treg-Targeting Training Network for the education of the next generation scientist in targeting the supressive capacity of regulatory T-cells specifically within tumours 2018
121 onCOMBINE Towards evidence-based combinations of approved and novel cancer drugs 2017
122 VIRO-FLOW Enabling Technologies and Drug Discovery: Continuous Flow Processes to Discover Novel Antiviral Inhibitors 2017
123 TECNEC Preclinical concept validation of tumor endothelial cell metabolism for novel anti-angiogenic therapy 2017
124 GlypStx Glycoprotein-based inhibitors of shiga-like toxin 2018
125 MNEMONIC Magnetic Enzyme Metal Organic Framework Composites 2017
126 GlycoEdit New Chemical Tools for Precision Glycotherapy 2017
127 CESYDE Ceramide Synthases in Diabetic Beta Cell Demise 2018
128 EnDurCrete New Environmental friendly and Durable conCrete, integrating industrial by-products and hybrid systems, for civil, industrial and offshore applications – EnDurCrete 2018
129 OMVCRC Engineered bacterial Outer Membrane Vesicles (OMVs) for colorectal cancer immunotherapy 2018
130 Drug the bug Identification of novel inhibitors to prevent microbial production of pro-diabetic metabolites 2017
131 Brain2Bee How dopamine affects social and motor ability - from the human brain to the honey bee 2018
132 NovAnI Indentification and optimisation of novel anti-infective agents using multiple hit-identification strategies 2018
133 NovInDXS Development of novel inhibitors of the anti-infective target DXS using dynamic combinatorial chemistry (DCC) 2018
134 BIONICS A biomimetic and neuroprotective delivery nanocapsule for the targeted treatment of post-ischemic stroke effects 2018
135 inhibitAUTO Towards a New Frontier in Autophagy Inhibition: The Development of a Novel Class of ChemicalProbes and Identification of Their Associated Biological Target 2018
136 SYNFOS Synthetic toolkit for fragment oriented synthesis 2018
137 IMMUNOMARK Omics integration for precision cancer immunotherapy 2018
138 FINDER FINDER: FIghtiNg DEngue viRus, a novel strategy for the development of fully protective antiviralsthat act by disrupting the DENV NS3/NS5 interaction 2018
139 ChemRAS Chemical probing of transcriptional RAS effectors 2019
140 CrysPINs Crystal structures of PIN proteins - CrysPINs 2018
141 EcoGemCoat Smart anticorrosion coatings based on nanocontainers loaded with novel, eco-friendly cationic gemini surfactants as efficient corrosion inhibitors for carbon steel in seawater. 2018
142 EMBRACE Elucidating Mechanisms of Bladder Cancer Metastasis 2018
143 UB-RASDisease The ubiquitin system in RAS-driven disease 2018
144 Za-AV Determination of physiologically relevant RNA substrate(s) and design of small-molecule inhibitors for Zα domains as potential intervention strategies for viral infections and autoimmunity 2018
145 Mtb CoaBC CoaBC from the Coenzyme A pathway of Mycobacterium tuberculosis as an antimicrobial drug target 2018
146 UTILIUM Unraveling The Immune Landscape In Uveal Melanoma 2018
147 rSAMs-NANO Nanoparticles with switchable shells for virus sensing and inhibition 2018
148 Proteasome in cancer Identification of the proteasome machinery targets in human cancer 2018
149 Target-N2O Targeting N2O emission hot-spots in dairy pastures for mitigation action: microbes, stable isotope methods and modelling 2018
150 RET PHOTOSWITCH THE DEVELOPMENT OF NOVEL PHOTOSWITCHABLE KINASE INHIBITORS 2018
151 ProCenDecl Synthesis and validation of chemical Probes for Centrosome Declustering: development of potent and selective anti-cancer agents. 2019
152 INFLA-AID The role of NLRC4 inflammasome in autoinflammatory diseases 2018
153 MATURE-NK MAnufacturing of TUmour-REactive Natural Killer cells 2018
154 HOPE Host Protective Engineering of Cancer Immunity by Targeting the Intracellular Immune Checkpoint NR2F6 2018
155 SelectiveTGFb-inhib Pro-tumorigenic effects of TGFb - elucidation of mechanisms and development of selective inhibitors 2018
156 ADDPRIME Multifunctional smart inhibitors for anti-corrosive coatings, enabling a significant reduction of maintenance costs on metallic surfaces 2018
157 iFermenter iFERMENTER - CONVERSION OF FORESTRY SUGAR RESIDUAL STREAMS TO ANTIMICROBIAL PROTEINS BY INTELLIGENT FERMENTATION 2018
158 PaSION A longitudinal assessment of treatment experience, symptoms and potential associations with biomarkers in cancer patients undergoing immune checkpoint inhibitor therapy 2018
159 CICURE Increasing complex I stability as a cure for mitochondrial diseases 2018
160 STIMUNO Searching for novel strategies improving cancer immunotherapy 2019
161 INTEGRATA Integrating chemical and biological approaches to target NAD production and signaling in cancer 2018
162 NextGen IO Exploiting the hypoxia response in T cells for Next-Generation Immuno-Oncology 2019
163 GreenCorrosionStop Commercialisation of a unifying green VCI anti-corrosion paper for the manufacturing industry and logistics companies 2018
164 p38_InTh Innovative therapeutic tools to ameliorate chemotherapy-induced cardiotoxicity 2018
165 IMPACCT Improved Patient Care by Combinatorial Treatment 2019
166 PHARMS Bacteriophage inhibition of antibiotic-resistant pathogenic microbes and founding for novel therapeutic strategies 2019
167 Sugar-Enable Influenza Virus - Sugar Interactions, From Glycan Arrays To Better Vaccines 2018
168 inCITe Seeing Citrulline: A Molecular Toolbox for Peptidyl Arginine Deiminases 2019
169 LeukemiaEnviron SIGNALING PROPENSITY IN THE MICROENVIRONMENT OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA 2019
170 ONCOBIOME Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. 2019
171 CRISPRsition Developing CRISPR adaptation platforms for basic and applied research 2019
172 BiocatSusChem Biocatalysis for Sustainable Chemistry – Understanding Oxidation/Reduction of Small Molecules by Redox Metalloenzymes via a Suite of Steady State and Transient Infrared Electrochemical Methods 2019
173 Cr Free REAL Development and testing of innovative Cr Free solution for REmoval of Anodic Layers 2019
174 PsychAID Psychiatric Disorders: ATX-inhibiting drugs as a new therapeutic option: Proof-of-Concept 2019
175 20SInhibitor Selective 20S proteasome inhibition for multiple myeloma therapy 2019
176 Human Repl Mech Mechanisms of human DNA replication 2019
177 Kinaddict Vulnerability of esophageal cancer to their addiction to kinase activities: evaluation and prediction of eSCC tumors responsiveness to kinase inhibitors. 2019
178 hsPCF-FRET Real-time characterisation of neuropeptide binding to a membrane receptor involved in pain and ischemic stroke 2019
179 CM_GF Biological relevance of the multiple infection unit as a novel target for antiviral development 2020
180 HONORLOGIC The Cultural Logic of Honor and Social Interaction: A Cross-Cultural Comparison 2019
181 AR-DDR Co-targeting androgen receptor signalling and DNA damage repair for precision therapy in advanced prostate cancer 2019
182 iRhomADAM Uncovering the role of the iRhom2-ADAM17 interaction in inflammatory signalling 2020
183 MGLycan Targeting hMGL-GalNAc interactions to reverse immune suppression in cancer 2019
184 PhotoStem Photoswitching molecules for the spatiotemporal control of cancer stem cells with light 2019
185 SingCelCD Single Cell approaches for the study of oncogenic processes during coeliac disease. 2019
186 3D NKCC1 Interdisciplinary approach to characterize the structure and the ion transport mechanism of NKCC1, a key target for brain disorders. 2019
187 IMMUcan Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts 2019
188 TargetDUBs Targeting ubiquitin processing in cancer and fibrosis: novel probes for the Ubiquitin Carboxy-Terminal Hydrolases 2019
189 MIMIC Deciphering how microbiota modulate anti-tumor immune responses in checkpoint therapy 2020
190 FEN INHIBITORS Development of Kinetoplastida Flap Endonuclease Inhibitors in Search for Novel Therapeutics 2020
191 MS4Drug An Innovative Mass Spectrometry-Based Workflow for Drug Discovery 2019
192 PePiPOM Peptide-functionalized POMs as biofilm disruption agents: searching for synergy in bactericidal materials 2019
193 LIBSED Libiguins: a remedy for the treatment of sexual dysfunctions 2019
194 EPICAN Inhibiting tumor cell plasticity by targeting the epigenome in breast cancer 2020
195 RespiriTB Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors 2019
196 RespiriNTM Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs 2019
197 UNPACK PD-L1 Molecular mechanism and inhibition of extracellular vesicle-mediated PD-L1 release in melanoma cells 2020
198 ProTeCT Proteasome as a target to combat trichomoniasis 2019
199 TOPAS Exploiting the Tumor Proteome Activity Status for Future Cancer Therapies 2019
200 CONNECT-2-CLINIC Pannexin1 nanobodies for the clinical treatment of liver disease 2020
201 TWO-BIRDS A feasibility study for SYT-510, a first-in-class drug to treat neuropsychiatric disorders through restoring overall balance in brain chemistry 2019
202 FRAME FRAME - tumor genome-based personalized anti-cancer vaccines off-the-shelf 2019
203 TRACER TRAF-STOP therapy to reduCe inflammation in athERosclerosis. 2020
204 AntiHelix DNA helicases in genome maintenance: from molecular and cellular mechanisms to specific inhibitors as potential drugs 2019
205 TaMIE Targeting MarA to Inhibit Efflux 2019
206 CYPNASH Validation of a novel class of cyclophilin inhibitors for the treatment of non-alcoholic steatohepatitis 2019
207 CHANCE Structure guided inhibition of IDOL to treat atherosclerosis and the metabolic syndrome 2019
208 G125 A minimally invasive, outpatient treatment for Gastroesophageal Reflux Disease (GERD), resulting in permanent relief from both GERD symptoms and life-long drug dependency 2019
209 CSI AurkA-MYC Conformational Shift Inducers (CSI): An atomistic level investigation of Aurora kinase A (AurkA)–MYC interaction and its distortion by CSI compounds 2019
210 Cenya Ex vivo cell labelling for in vivo imaging applied to cell therapeutics 2019
211 Hydroptics Photonics sensing platform for process optimisation in the oil industry 2019
212 EcoFoil Innovative, sustainable and globally unique storage method for food preservation 2019
213 MEPHOS Shaping the Mechano-Pharmacological properties of Microparticles and Extracellular Vesicles for the Treatment of Osteoarthritis 2020
214 MEISi Druggable Small Molecule Inhibitor of MEIS Proteins 2019
215 STI-001 Turn Cancer Immunotherapy Effective in Most Patients 2019
216 PARPinhibit A systems biology approach to tackle PARP-inhibitors resistance and identify novel therapeutic targets to overcome it 2020
217 DECISION DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES 2020
218 ISOLDA Improved Vaccination Strategies for Older Adults 2020
219 DDREAMM Dna Damage REsponse: Actionabilities, Maps and Mechanisms 2020
220 PANACHE Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases. 2020
221 EDUC8 Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity 2020
222 inhibiTOR Novel selective mTORC1 inhibitors 2020
223 Glue2Degrade Therapeutic hijacking of E3 Ligases 2020
224 PP-MAGIC (Photo-)Control of Persisters: Targeting the Magic Spot 2020
225 TESTIMONY Tumor Endothelial Cells: Gatekeepers Of Anti-Tumor Immunity 2020
226 BRCAstem Monitoring cancer stem cell dynamics and therapeutic response in BRCA2-deficient breast tumour cells 2020
227 FBC predisposition Unraveling novel Familial Breast Cancer (FBC) predisposition genes. 2020
228 NetriCan Characterization of the role of netrin-1 in the regulation of the Epithelial-to-Mesenchymal Transition during tumor progression. 2020
229 TGF-BTB Transforming Growth Factor – Bench To Bedside. Towards a better understanding of TGF-β isoform specific signalling in health and disease 2020
230 FluAttack Validation of a novel antiviral drug candidate against influenza 2020
231 RegARcis Role of the SWI/SNF complex in the Androgen Receptor cistrome regulation 2020
232 RabTarget4Metastasis Targeting Rab27A with covalent inhibitors for the treatment of metastatic breast cancer 2020
233 ANTIBIOCLICKS BioInspired Clicked Siderophore-Antibiotics 2020
234 PyroSuL Pyrophosphate Surrogates with Low polarity as part of glycosyltransferase ligands 2021
235 ICG68-PROG Imaging of c-Met aberrant cancers with Gallium-68 chelators for positron emission tomography 2020
236 DIM-CrIC Decreasing Pancreatic Adenocarcinoma-related Inflammation using small molecule inhibitors of STING 2020
237 HT4PD The role of the serotonin 5-HT4 receptor in motor and non-motor symptoms of Parkinson’s disease 2021
238 TARGETOF Mass cytometry nanotools for intracellular target engagement. Towards precision medicine. 2021